| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.04. | KORU Medical Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.03. | KORU Medical's Freedom60 pump receives EU MDR certification | 1 | Investing.com | ||
| 13.03. | KORU Medical Q4 2025 slides: 23% growth, CEO transition announced | 3 | Investing.com | ||
| KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 12.03. | KORU Medical steigert Umsatz im 4. Quartal um 23 % und kündigt CEO-Wechsel an | - | Investing.com Deutsch | ||
| 12.03. | Earnings call transcript: KORU Medical Systems übertrifft Prognosen in Q4 2025, Aktie gibt dennoch nach | 5 | Investing.com Deutsch | ||
| 12.03. | KORU Medical Systems: EPS übertrifft Schätzungen um 0,03 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 12.03. | KORU Medical Systems, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | KORU Medical Systems, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.02. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 29.01. | KORU Medical's infusion system cleared for UCB's RYSTIGGO therapy | 7 | Investing.com | ||
| 12.01. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.01. | KORU Medical Systems sees Q4 revenue of $10.9M | 1 | Seeking Alpha | ||
| 03.01. | KORU Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 30.12.25 | KORU Medical beantragt FDA-Zulassung für Gerät zur Brustkrebstherapie | 1 | Investing.com Deutsch | ||
| 30.12.25 | KORU Medical submits FDA application for breast cancer therapy device | 2 | Investing.com | ||
| 25.11.25 | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.11.25 | KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 | 422 | Business Wire | KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions... ► Artikel lesen | |
| 13.11.25 | Koru Medical Systems stock maintains Buy rating at Canaccord on strong growth | 1 | Investing.com | ||
| 13.11.25 | KORU Medical Systems projects 20%-22% revenue growth for 2025 while advancing oncology and international expansion | 3 | Seeking Alpha | ||
| 12.11.25 | KORU Medical übertrifft im Q3 2025 die Umsatzerwartungen und hebt Prognose an | 2 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 21,280 | +1,48 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | +1,18 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| BRIGHTSPRING HEALTH SERVICES | 46,040 | -0,04 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| HEARTFLOW | 29,020 | +5,68 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,740 | +5,34 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner | ||
| BETA BIONICS | 11,815 | +11,04 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LEMAITRE VASCULAR | 100,00 | 0,00 % | LeMaitre Vascular, Inc.: LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 | ||
| PRIVIA HEALTH GROUP | 23,120 | +0,43 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| STRAUMANN | 95,50 | -0,10 % | Straumann Holding AG: Einladung: Straumann Group - Umsatzzahlen 1. Quartal 2026 Webcast | Straumann Holding AG
/ Schlagwort(e): Quartalsergebnis
Einladung: Straumann Group - Umsatzzahlen 1. Quartal 2026 Webcast
08.04.2026 / 11:00 CET/CEST
Datum: Mittwoch... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,510 | +0,70 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | +1,78 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| SIGHT SCIENCES | 3,820 | +3,52 % | Sight Sciences, Inc.: Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing... ► Artikel lesen | |
| CERIBELL | 19,550 | +2,25 % | Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results | SUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 3,385 | +2,89 % | Oncology Institute reports $1.8M Medicare savings in latest period |